Biocare Medical LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Oct 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 11, 2026The maintenance fee for Systems and methods for anti-Uroplakin III antibodies (US 10,316,103) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
- 1 fee due Apr 1, 2027The maintenance fee for Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer (US 10,429,390) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
- 1 fee due Nov 19, 2027The maintenance fee for Biological sample processing systems and methods (US 10,656,057) comes due Nov 19, 2027. Unpaid by May 19, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,501,434 | Method for processing non-liquid biological samples with dynamic application of a processing liquid In force · USPTO record | In force | USPTO record | |
| US 8,852,592 | Systems and methods for anti-PAX8 antibodies In force · USPTO record | In force | USPTO record | |
| US 9,417,243 | Systems and methods for anti-PAX8 antibodies In force · USPTO record | In force | USPTO record | |
| US 9,442,049 | Efficient processing systems and methods for biological samples In force · USPTO record | In force | USPTO record | |
| US 8,765,476 | Methods and systems for efficient automatic slide staining in immunohistochemistry sample processing In force · USPTO record | In force | USPTO record | |
| US 10,316,103 | Systems and methods for anti-Uroplakin III antibodies In force · USPTO record | In force | USPTO record | |
| US 9,945,763 | Methods and systems for immunohistochemistry heat retrieval of biological samples In force · USPTO record | In force | USPTO record | |
| US 9,429,577 | Anti-uroplakin II antibodies systems and methods In force · USPTO record | In force | USPTO record | |
| US 9,823,251 | Anti-Uroplakin II antibodies systems and methods In force · USPTO record | In force | USPTO record | |
| US 10,429,390 | Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 15: 1 lapsed for an unpaid fee · 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 no status recorded